Skip to main content
SpringerLink
Log in
Book cover

Endocrine Autoimmunity and Associated Conditions pp 269–284Cite as

Vitiligo

  • Chapter

Part of the book series: Immunology and Medicine Series ((IMME,volume 27))

Abstract

Vitiligo is an acquired idiopathic hypomelanotic disorder characterized by circumscribed depigmented macules. There is frequently a family history of the condition or of autoimmune endocrine disease. Vitiligo can lead to social embarrassment, psychological disturbance, and cosmetic disability.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Howitz J, Brodthagen H, Schwartz M et al. Prevalence of vitiligo. Arch Dermatol. 1977; 113: 47–52.

    Article  PubMed  CAS  Google Scholar 

  2. Das SK, Majumder PP, Chakraborty R et al. Studies on vitiligo. I: Epidemiological profile in Calcutta, India. Genet Epidemiol. 1985;2:71–78.

    Article  PubMed  CAS  Google Scholar 

  3. Meollmann G, Klein-Angerer S, Scollay DA, Nordlund JJ, Lerner AB. Extracellular granular material and degeneration of keratinocytes in the normally pigmented epidermis of patients with vitiligo. J Invest Dermatol. 1982;79:321–330.

    Article  Google Scholar 

  4. Le Poole IC, van den Wijngaard RMJGJ, Westerhof W et al. Presence or absence of melanocytes in vitiligo lesions: an immunohistochemical investigation. J Invest Dermatol. 1993;100:816–822.

    Article  PubMed  Google Scholar 

  5. Bleehen SS. Vitiligo. In: Klaus SN, ed. Pigment Cell, Vol 5. Basel: Karger AG; 1979:54.

    Google Scholar 

  6. Ortonne JP, Mosher DB, Fitzpatrick TB. Vitiligo and other hypomelanosis of hair and skin. New York: Plenum Press; 1983:257–258.

    Book  Google Scholar 

  7. Butterworth T, Stream LP. Vitiligo. Baltimore: Williams and Wilkins; 1962:4–6.

    Google Scholar 

  8. Majumder PP, Das DK, Li CC. A genetic model for vitiligo. Am J Hum Genet. 1988;43:119–125.

    PubMed  CAS  Google Scholar 

  9. Majumder PP, Nordlund JJ, Nath SK. Pattern of familial aggregation of vitiligo. Arch Dermatol. 1993;129:994–998.

    Article  PubMed  CAS  Google Scholar 

  10. Ando I, Chi HI, Nakagawa H, Otsuka F. Differences in clinical features and HLA antigens between familial and non-familial vitiligo of non-segmental type. Br J Dermatol. 1993; 129: 408–410.

    Article  PubMed  CAS  Google Scholar 

  11. Orrecchia GL, Perfetti L, Malagoli P et al. Vitiligo is associated with a significant increase in HLA-A30, Cw6 and DQw3 and a decrease in C4AQ0 in Northern Italian patients. Dermatology. 1992;185:123–127.

    Article  Google Scholar 

  12. Venkataram MN, White AG, Lenny WA et al. HLA antigens in Omani patients with vitiligo. Clin Exp Dermatol. 1995;20:35–37.

    Article  PubMed  CAS  Google Scholar 

  13. Schallreuter KU, Levenig C, Kuhnl P et al. Histocompatibility antigens in vitiligo: Hamburg study on 102 patients from Northern Germany. Dermatology. 1993;187:186–192.

    Article  PubMed  CAS  Google Scholar 

  14. Venneker GT, Westerhof W, de Vries IJ et al. Molecular heterogeneity of the fourth component of complement (C4) and its genes in vitiligo. J Invest Dermatol. 1992;99:853–858.

    Article  PubMed  CAS  Google Scholar 

  15. Kahl LE, Atkinson JP. Autoimmune aspects of complement deficiency. Clin Aspects Autoimmun. 1988;5:8–20.

    Google Scholar 

  16. Cunliffe WJ, Hall DJ, Newell DJ et al. Vitiligo, thyroid disease and autoimmunity. Br J Dermatol. 1968;80:135–139.

    Article  PubMed  CAS  Google Scholar 

  17. Parrish JA, Fitzpatrick TB, Shea C et al. Photochemotherapy of vitiligo. Arch Dermatol. 1976;112:1531–1534.

    Article  PubMed  CAS  Google Scholar 

  18. Dunlop D. Eighty-six cases of Addison’s disease. Br Med J. 1963;ii:887–891.

    Article  Google Scholar 

  19. Tosti A, Bardazzi F, Tosti G et al. Audiologic abnormalities in cases of vitiligo. J Am Acad Dermatol. 1987;17:230–233.

    Article  PubMed  CAS  Google Scholar 

  20. Lerner AB, Halaban R, Klaus SN et al. Transplantation of human melanocytes. J Invest Dermatol. 1987;89:219–224.

    Article  PubMed  CAS  Google Scholar 

  21. Macaron C, Winter RJ, Traisman HS et al. Vitiligo and juvenile diabetes mellitus. Arch Dermatol. 1977;113:1515–1517.

    Article  PubMed  CAS  Google Scholar 

  22. Hegedus L, Heidenheim M, Gervil M et al. High frequency of thyroid dysfunction in patients with vitiligo. Acta Derm Venereol. 1994;74:120–123.

    PubMed  CAS  Google Scholar 

  23. Schallreuter KU, Lemke R, Brandt O et al. Vitiligo and other diseases: coexistence or true association? Dermatology. 1994;188:269–275.

    Article  PubMed  CAS  Google Scholar 

  24. Neufeld M, Maclaren NK, Blizzard RM. Two types of autoimmune Addison’s disease associated with different polyglandular autoimmune syndromes. Medicine (Baltimore). 1981;60:355–362.

    Article  CAS  Google Scholar 

  25. Ahonen P, Koskimies S, Lokki ML et al. The expression of autoimmune polyglandular disease type I appears associated with several HLA-A antigens but not with HLA-DR. J Clin Endocrinol Metab. 1988;66:1151–1157.

    Article  Google Scholar 

  26. Tsokos GC, Gorden P, Antonovych T et al. Lupus nephritis and other autoimmune features in patients with diabetes mellitus due to autoantibody to insulin receptors. Ann Intern Med. 1985;102:176–181.

    Article  PubMed  CAS  Google Scholar 

  27. Lerner AB. On the etiology of vitiligo and gray hair. Am J Med. 1971;51:141–147.

    Article  PubMed  CAS  Google Scholar 

  28. Nordlund JJ, Todes-Taylor N, Albert DM et al. The presence of vitiligo and poliosis in patients with uveitis. J Am Acad Dermatol. 1981;4:528–536.

    Article  PubMed  CAS  Google Scholar 

  29. Cowan CL, Haider RM, Grimes PE, Chakrabarti SG, Kenney JA. Ocular disturbances in vitiligo. J Am Acad Dermatol. 1986;15:17–24.

    Article  PubMed  Google Scholar 

  30. Barnes L. Vitiligo and the Vogt-Koyanagi-Harada syndrome. Dermatol Clin. 1988;6:229–239.

    PubMed  CAS  Google Scholar 

  31. Frenk E. Depigmentation vitiligineuses chez des patients atteints de melanomes malins. Dermatologica. 1969;1139:84–91.

    Article  Google Scholar 

  32. Veharaa M, Mayauchi H, Tanaka S. Diminished contact sensitivity response in vitiliginous skin. Arch Dermatol. 1984;120:195–198.

    Article  Google Scholar 

  33. Morelli JG. The cause and treatment of vitiligo. Curr Opin Dermatol. 1995;1:105–108.

    Google Scholar 

  34. Ortonne JP, Bose SK. Vitiligo: where do we stand? Pigment Cell Res. 1994;6:61–72.

    Article  Google Scholar 

  35. Lerner AB. Vitiligo. J Invest Dermatol. 1959;32:285–310.

    Article  PubMed  CAS  Google Scholar 

  36. Al’Abadie MSK, Senior HJ, Bleehen SS, Gawkrodger DJ. Neuropeptide and neuronal marker studies in vitiligo. Br J Dermatol. 1994;131:160–165.

    Article  CAS  Google Scholar 

  37. AlAbadie MSK, Warren MA, Bleehen SS, Gawkrodger DJ. Morphologic observations on the dermal nerves in vitiligo: an ultrastructural study. Int J Dermatol. 1995;34:837–840.

    Article  CAS  Google Scholar 

  38. Mozzanica N, Villa ML, Foppa S et al. Plasma a-melanocyte-stimulating hormone,-endorphin, met-enkephalin and natural killer cell activity in vitiligo. J Am Acad Dermatol. 1992;26:693–700.

    Article  PubMed  CAS  Google Scholar 

  39. Bleehen SS, Pathak MA, Hori Y et al. Depigmentation of skin with 4-isopropylcatechol mercaptoamines, and other compounds. J Invest Dermatol. 1968;50:103–117.

    PubMed  CAS  Google Scholar 

  40. Schallreuter KU, Wood JM, Ziegler I et al. Defective tetrahydrobiopterin and catecholamine biosynthesis in the depigmentation disorder vitiligo. Biochim Biophys Acta. 1994; 1226:181–192.

    Article  PubMed  CAS  Google Scholar 

  41. Le Poole C, van der Wijngaard R, Smit NPM et al. Catechol-o-methyltransferase in vitiligo. Arch Dermatol Res. 1994;286:81–86.

    Article  PubMed  Google Scholar 

  42. Schallreuter KU, Wood JM, Pittelkow MR et al. Regulation of melanin biosynthesis in the human epidermis by tetrahydrobiopterin. Science. 1994;2631:21444–21446.

    Google Scholar 

  43. Schallreuter KU, Wood JM, Berger I. Low catalase levels in the epidermis of patients with vitiligo. J Invest Dermatol. 1991;97:1081–1085.

    Article  PubMed  CAS  Google Scholar 

  44. Schallreuter KU, Wood JM, Lemke KR, Levenig C. Treatment of vitiligo with a topical application of pseudocatalase and calcium in combination with short-term UVB exposure: a case study on 33 patients. Dermatology. 1995;190:223–229.

    Article  PubMed  CAS  Google Scholar 

  45. Naughton GK, Eisenger M, Bystryn JC. Antibodies to normal melanocytes in vitiligo. J Exp Med. 1983;158:246–251.

    Article  PubMed  CAS  Google Scholar 

  46. Bystryn JC. Serum antibodies in vitiligo patients. Clin Dermatol. 1989;2:136–145.

    Article  Google Scholar 

  47. Harning R, Cui J, Bystryn JC. Relationship between the incidence and level of pigment cell antibodies and disease activity in vitiligo. J Invest Dermatol. 1991;97:1078–1080.

    Article  PubMed  CAS  Google Scholar 

  48. Cui J, Arita Y, Bystryn JC. Cytolytic antibodies to melanocytes in vitiligo. J Invest Dermatol. 1993;100:812–815.

    Article  PubMed  CAS  Google Scholar 

  49. Yu CL, Kao CH, Yu HS. Co-existence and relationship of antikeratinocyte and antimelano-cyte antibodies in patients with non-segmental-type vitiligo. J Invest Dermatol. 1993; 100: 823–828.

    Article  PubMed  CAS  Google Scholar 

  50. Abdel Nasser MB, Gollnick H, Orfanos CE. Evidence of primary involvement of keratino-cytes in vitiligo. Arch Dermatol Res. 1991;283:47–48.

    Google Scholar 

  51. Gilhar A, Zelickson B, Ulman Y, Etzioni A. In vivo destruction of melanocytes by the IgG fraction of serum from patients with vitiligo. J Invest Dermatol. 1995;105:683–686.

    Article  PubMed  CAS  Google Scholar 

  52. Song YH, Connor E, Li Y et al. The role of tyrosinase in autoimmune vitiligo. Lancet. 1994; 344:1049–1052.

    Article  PubMed  CAS  Google Scholar 

  53. Grimes PE, Ghoneum M, Stockton T, Payne C, Kelly P, Alfred L. T-cell profiles in vitiligo. J Am Acad Dermatol. 1986;14:196–201.

    Article  PubMed  CAS  Google Scholar 

  54. Abdel Nasser MB, Kruger S, Krasagakis K et al. Evidence for involvement of both cell mediated and humoral immunity in generalized vitiligo. J Invest Dermatol. 1991;96:1024.

    Google Scholar 

  55. Gross A, Tapis FJ, Mosea W et al. Mononuclear cell subpopulations and infiltrating lymphocytes in erythema dyschromiscum perstans and vitiligo. Histol Histopathol. 1987;2: 277–287.

    PubMed  CAS  Google Scholar 

  56. Durham-Pierre DG, Walters CS, Halder RM et al. Natural killer cell and lymphokine-associated killer cell activity against melanocytes in vitiligo. J Am Acad Dermatol. 1995;33: 26–30.

    Article  PubMed  CAS  Google Scholar 

  57. Gilhar A, Aizen E, Ohana N, Etzioni A. Vitiliginous vs pigmented skin response to intradermal administration of interferon gamma. Arch Dermatol. 1993;129:600–604.

    Article  PubMed  CAS  Google Scholar 

  58. El Magrabi IAS. Clinical, histological and immunopathological studies on vitiligo. PhD thesis, University of Sheffield, 1990.

    Google Scholar 

  59. Norris DA. Cytokine modulation of adhesion molecules in the regulation of immunocyto-toxicity of epidermal targets. J Invest Dermatol. 1990;95:111S–120S.

    Article  PubMed  CAS  Google Scholar 

  60. Al Badri AMT, Foulis AK, Todd PM et al. Abnormal expression of MHC class II and ICAM-1 by melanocytes in vitiligo. J Pathol. 1993;169:203–206.

    Article  PubMed  Google Scholar 

  61. Campbell IL, Harrison LC. Molecular pathology of type I diabetes. Mol Biol Med. 1990;7: 299–309.

    PubMed  CAS  Google Scholar 

  62. Zheng RQH, Abney ER, Grubeck-Loebenstein B et al. Expression of intercellular adhesion molecule-1 and lymphocyte function-associated antigen-3 on human thyroid epithelial cells in Graves’ and Hashimoto’s diseases. J Autoimmun. 1990;3:727–736.

    Article  PubMed  CAS  Google Scholar 

  63. Nakazawa K, Bonnard M, Damour O, Collombel C. Functional role of E-cadherin in melanocyte-keratinocyte adhesion in vitro. Melanoma Res. 1995;5(2):40.

    Article  Google Scholar 

  64. Morelli JG, Kincannon J, Yohn JJ et al. Leukotriene C4 and TGF-α are stimulators of human melanocyte migration in vivo. J Invest Dermatol. 1992;98:290–295.

    Article  PubMed  CAS  Google Scholar 

  65. Morelli JG, Yohn JJ, Zekman T, Norris DA. Melanocyte movement in vitro: role of matrix proteins and integrin receptors. J Invest Dermatol. 1993;101:605–608.

    Article  PubMed  CAS  Google Scholar 

  66. Hedley SJ, Gawkrodger DJ, Weetman AP, MacNeil S. Extracellular matrix proteins stimulate melanocyte tyrosinase. Melanoma Res. 1995;5(2):38–39.

    Article  Google Scholar 

  67. Lerner AB, Shiohara T, Boissy RE et al. A mouse model for vitiligo. J Invest Dermatol. 1986; 87:299–304.

    Article  PubMed  CAS  Google Scholar 

  68. Gilhar A, Pillar T, Eidelman S, Etzioni A. Vitiligo and idiopathic guttate hypomelanosis. Repigmentation of skin following engraftment onto nude mice. Arch Dermatol. 1989;125: 1363–1366.

    Article  PubMed  CAS  Google Scholar 

  69. Oliver EA, Schwartz L, Warren LH. Occupational leukoderma. Arch Dermatol Syphilol. 1940;101:163–169.

    Google Scholar 

  70. Malten KE, Seutter E, Hara I, Nakajima T. Occupational vitiligo due to paratertiary butyl phenol and homologues. Trans St John’s Dermatol Soc. 1971;57:115–131.

    CAS  Google Scholar 

  71. Gellin GA, Possick PA, Perone VB. Depigmentation from 4-tertiary butyl catechol. J Invest Dermatol. 1970;55:190–197.

    Article  PubMed  CAS  Google Scholar 

  72. Nordlund JJ, Lerner AB. Vitiligo: is it important? Arch Dermatol. 1982;118:5–8.

    Article  PubMed  CAS  Google Scholar 

  73. Barona MI, Arrunategui A, Falabella R, Alzate A. An epidemiological case-control study in a population with vitiligo. J Am Acad Dermatol. 1995;33:621–625.

    Article  PubMed  CAS  Google Scholar 

  74. Taylor JS, Maibach HI, Fisher AA, Bergfeld WF. Contact leukoderma associated with the use of hair colors. Cutis. 1993;52:273–280.

    PubMed  CAS  Google Scholar 

  75. Grimes PE. Vitiligo: an overview of therapeutic approaches. Dermatol Clin. 1993;11:325–338.

    PubMed  CAS  Google Scholar 

  76. Wildfang IL, Jacobsen FK, Thestrup-Pedersen K. PUVA treatment of vitiligo: a retrospective study of 59 patients. Acta Derm Venereol. 1992;72:305–306.

    PubMed  CAS  Google Scholar 

  77. Anstey A, Hawk JLM. PUVA treatment of vitiligo. Br J Dermatol. 1994; 131(44): 18.

    Google Scholar 

  78. Orrecchia G, Perfetti L. Photochemotherapyy with topical khellin and sunlight in vitiligo. Dermatology. 1992;184:120–123.

    Article  Google Scholar 

  79. Passi S, Picardo M, De Luca M et al. Treatment of vitiligo with an antioxidant pool. Melanoma Res. 1995;5(2):25.

    Article  Google Scholar 

  80. Zachariae H, Zachariae C, Deleuran B, Kristensen P. Autotransplantation in vitiligo: treatment with epidermal grafts and cultured melanocytes. Acta Derm Venereol. 1993;73: 46–48.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Dermatology, University of Sheffield Royal Hallamshire Hospital, Sheffield, S10 2JF, UK

    D. J. Gawkrodger

Authors
  1. D. J. Gawkrodger
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Department of Medicine Clinical Sciences Centre, University of Sheffield Northern General Hospital, Sheffield, S5 7AU, UK

    A. P. Weetman

Rights and permissions

Reprints and permissions

Copyright information

© 1998 Springer Science+Business Media Dordrecht

About this chapter

Cite this chapter

Gawkrodger, D.J. (1998). Vitiligo. In: Weetman, A.P. (eds) Endocrine Autoimmunity and Associated Conditions. Immunology and Medicine Series, vol 27. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-5044-6_13

Download citation

  • DOI: https://doi.org/10.1007/978-94-011-5044-6_13

  • Publisher Name: Springer, Dordrecht

  • Print ISBN: 978-94-010-6118-6

  • Online ISBN: 978-94-011-5044-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation